Contact Us

Yes. USP24 rescue experiments require attention to multiple substrate dependencies: • Construct design: USP24 is a large protein (~2,600 amino acids); use codon-modified sequences with C-terminal tags (FLAG, HA). Full-length cloning requires careful vector selection. • Catalytically-dead rescue: active site cysteine mutation serves as the deubiquitinase specificity control. • Multi-substrate rescue interpretation: USP24 has reported roles in p53 stability, DDB2 regulation, and autophagy — rescue effects on different substrates may show different kinetics and should be assessed independently. • Functional readout: rescue should restore substrate-specific deubiquitination patterns and downstream phenotypes (DNA damage response, autophagy flux). HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether USP19 is required for its reported functions in ER-associated protein quality control, HSP90 client stability, or unconventional secretion pathways. Overexpression is useful for testing whether elevated USP19 is sufficient to drive substrate stabilization or alter ER stress responses. For USP19 research, the EDITGENE Knockout line in HAP1 is the more rigorous starting tool because USP19's ER membrane localization and multifunctional domain architecture make precise functional dissection challenging — complete loss provides the cleanest baseline for mechanistic analysis. Rescue with wild-type, catalytically-dead, or domain-deletion USP19 constructs is essential for mapping function to specific structural elements.

Yes. USP19 rescue experiments require attention to ER membrane targeting and isoform considerations: • Construct design: USP19 has both ER membrane-anchored and soluble isoforms. Use codon-modified sequences with C-terminal tags (FLAG, HA); the C-terminal transmembrane domain in the membrane-anchored isoform is essential for ER targeting. • Isoform-specific rescue: ER-anchored versus soluble USP19 may have distinct substrate preferences — rescue with each isoform separately is informative for mechanistic dissection. • Catalytically-dead rescue: active site cysteine mutation serves as the deubiquitinase specificity control; CS-domain (CHORD-SGT1) deletion mutants probe HSP90 client engagement. • Functional readout: rescue should restore ER quality control phenotypes and HSP90 client stability. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether USP10 is required for its established functions — particularly p53 stabilization, AMPK signaling regulation, and stress granule dynamics. Overexpression is useful for testing whether elevated USP10 is sufficient to stabilize substrates, or for studying USP10 in cancer contexts where it has been reported as both tumor-suppressive and tumor-promoting depending on cellular context. For USP10 research, the EDITGENE Knockout line in HAP1 is the more rigorous starting point — USP10 has multiple reported substrates with context-dependent effects, and complete loss in a near-haploid background provides cleaner substrate dependency mapping than partial reduction. Rescue with wild-type or catalytically-dead USP10 is the standard control for assigning observed effects to deubiquitinase activity.

Yes. USP10 rescue experiments require attention to substrate-specific deubiquitinase activity: • Construct design: use a codon-modified USP10 sequence with a C-terminal tag (FLAG, HA). USP10 is large (~798 amino acids); both tag positions are tolerated. • Catalytically-dead rescue: the C424A mutation in the active site abolishes deubiquitinase activity and is the standard specificity control for distinguishing enzymatic from scaffolding functions. • Substrate-specific interpretation: USP10 has multiple substrates (p53, AMPK, G3BP1) with potentially distinct rescue kinetics — assess each substrate's stability independently when interpreting rescue. • Functional readout: rescue should restore substrate stability (cycloheximide chase) and stress granule dynamics (imaging) to wild-type levels. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on the experimental question, though for UNC93A — which is poorly characterized in the literature — the framing question itself often needs to come first. The Knockout line is most useful for unbiased discovery: identifying pathways and phenotypes affected by UNC93A loss without prior assumptions. Overexpression is more useful once candidate functions have been proposed. For an emerging factor like UNC93A, the EDITGENE Knockout line in Huh-7 is the higher-value starting tool. Discovery-oriented experiments (transcriptomics, phenotypic screening) in the knockout are more informative than overexpression at this stage. Note that UNC93A should not be confused with UNC93B1, which is a well-characterized TLR trafficking chaperone — the two proteins have distinct biology.

Yes, and rescue experiments are particularly important for UNC93A given its emerging status: • Construct design: use a codon-modified UNC93A sequence with a small C-terminal tag (FLAG, HA). For under-characterized membrane-related proteins, both tag positions should be tested to confirm functional rescue. • Avoid confusion with UNC93B1: ensure rescue constructs use the correct UNC93A sequence — UNC93B1 is a separate, much better-characterized protein involved in TLR trafficking. Cross-contamination between these reagents is a known issue. • Discovery-oriented rescue: rescue at the discovery phase establishes which knockout phenotypes are UNC93A-dependent versus off-target effects of editing — particularly important for emerging factors. • Functional readout: rescue should restore phenotypes identified in discovery transcriptomics or phenotypic profiling experiments. Huh-7 cells transduce efficiently with lentivirus and support stable rescue line generation; the hepatocellular background should be considered when interpreting rescue effects on liver-specific phenotypes.

The choice depends on whether you are studying UCHL1's deubiquitinase activity, its ubiquitin ligase activity at higher concentrations, or its role in neurodegeneration. The Knockout line is the standard tool for asking whether UCHL1 is required for ubiquitin homeostasis, neuronal function, or — relevantly in A-549 — its reported roles in cancer biology and lung cancer progression. Overexpression is useful for studying UCHL1's gain-of-function activity in neurodegeneration and for distinguishing concentration-dependent enzymatic functions. For UCHL1 research, the EDITGENE Knockout line in A-549 is particularly informative for cancer biology questions because A-549 is the standard NSCLC model. Rescue with wild-type or catalytically-dead (C90S) UCHL1 is essential — UCHL1 has both deubiquitinase and ligase activities, and concentration-dependent rescue is informative for distinguishing these functions.

Yes. UCHL1 rescue experiments have a well-defined framework given UCHL1's prominence in neurodegeneration research: • Construct design: use a codon-modified UCHL1 sequence with a small N- or C-terminal tag (FLAG, HA). UCHL1 is small (~223 amino acids); both tag positions are tolerated. • Catalytically-dead rescue: the C90S mutation abolishes deubiquitinase activity and is essential for distinguishing UCHL1's enzymatic activity from its concentration-dependent ligase activity. • Concentration-dependent rescue: UCHL1 has been reported to exhibit ligase activity at high concentrations — titrate expression levels to physiological ranges using inducible systems where possible. • Inhibitor specificity controls: rescue with wild-type versus catalytic mutants helps distinguish on-target effects of UCHL1 inhibitors (LDN-57444, others) from off-target activities. A-549 transduces efficiently with lentivirus and supports stable rescue line generation; the NSCLC background is particularly relevant for cancer-focused rescue studies.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether UBLCP1 is required for nuclear 26S proteasome regulation — its principal characterized function. Overexpression is useful for testing whether elevated UBLCP1 phosphatase activity is sufficient to alter proteasome activity in different cellular compartments. For UBLCP1 research, the EDITGENE Knockout line in HAP1 is the more rigorous starting tool because UBLCP1 functions through dephosphorylation of the proteasome regulatory particle in the nucleus — complete loss in a clean genetic background reveals nuclear-specific proteasome regulation more directly than partial reduction in diploid cells. Rescue with wild-type or phosphatase-dead UBLCP1 is the standard specificity control.

Yes. UBLCP1 rescue experiments require attention to nuclear localization and phosphatase activity: • Construct design: use a codon-modified UBLCP1 sequence with a C-terminal tag (FLAG, HA). UBLCP1 contains a nuclear localization signal — N-terminal tags can interfere with nuclear targeting. • Phosphatase-dead rescue: an active site mutation (typically targeting the catalytic cysteine or substrate-binding residues) is essential for distinguishing phosphatase activity from scaffolding functions on the proteasome. • Localization validation: confirm nuclear localization of exogenous UBLCP1 by immunofluorescence before assessing proteasome regulatory functions. • Functional readout: rescue should restore nuclear 26S proteasome activity and proteasome regulatory particle phosphorylation patterns. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying UBE3A's role in ubiquitin ligase biology or modeling Angelman syndrome / 15q11-q13 duplication disorders. The Knockout line is the standard tool for both — Angelman syndrome is caused by loss of maternal UBE3A expression. Overexpression is useful for studying 15q duplication syndromes where elevated UBE3A is the disease-driving change. For UBE3A research, the EDITGENE Knockout line in HEK293 provides a tractable mechanistic platform for dissecting substrate ubiquitination and ligase activity, though it is not a neuronal context — UBE3A's most disease-relevant functions are in neurons. Rescue with wild-type, catalytically-dead (C840A), or disease-associated mutant UBE3A is informative for genotype-function correlation.

Yes. UBE3A rescue experiments require careful attention to imprinting and dosage considerations: • Construct design: use a codon-modified UBE3A sequence with a C-terminal tag (FLAG, HA). UBE3A's HECT domain at the C-terminus contains the active site cysteine — bulky C-terminal tags should be avoided in favor of small epitope tags. • Catalytically-dead rescue: the C840A mutation in the active site cysteine abolishes ubiquitin ligase activity and is the standard specificity control. • Isoform considerations: UBE3A has three protein isoforms with distinct N-termini and partially different subcellular distributions — rescue with specific isoforms can address isoform-specific functions. • Dosage matters: UBE3A overexpression beyond endogenous levels can produce 15q duplication-like phenotypes — titrate to physiological levels using inducible systems for Angelman syndrome-focused research. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether UBE2W is required for its distinctive function — N-terminal monoubiquitination of substrates lacking accessible lysines. Overexpression is useful for testing whether elevated UBE2W activity is sufficient to ubiquitinate substrate N-termini in vitro or in cells. For UBE2W research, the EDITGENE Knockout line in HAP1 is the more interpretable tool because UBE2W has a unique substrate specificity (N-terminal residues) that distinguishes it from other E2 enzymes — complete loss reveals the cellular dependency on this unusual ubiquitination mode. Rescue with wild-type or catalytically-dead UBE2W is essential for specificity validation.

Yes. UBE2W rescue experiments require attention to its unique N-terminal substrate specificity: • Construct design: use a codon-modified UBE2W sequence with a C-terminal tag (FLAG, HA). UBE2W is small (~151 amino acids); N-terminal tags should be avoided as they may interfere with the unusual substrate engagement mechanism. • Catalytically-dead rescue: the C91A or C91S mutation in the active site abolishes ubiquitin transfer activity and is the standard specificity control. • Substrate accessibility considerations: UBE2W targets substrate N-termini, which can be obscured by N-terminal tags on the substrate itself — endogenous substrate analysis is generally more informative than tagged substrate rescue assays. • Functional readout: rescue should restore N-terminal ubiquitination of identified substrates (assessed by N-terminal-specific ubiquitin proteomics). HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.